ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.46B |
| Enterprise Value | 2.65B |
| P/E Ratio | 84.14 |
| PEG Ratio | 4.77 |
| Price/Sales Ratio | 2.49 |
| Price/Book Ratio | 3.75 |
| Enterprise/Revenue | 2.83 |
| Enterprise/EBITDA | 19.52 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.03 |
| Operating Margin | 0.06 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 870.79M |
| Revenue/Share | 3.26 |
| Gross Profit | 586.75M |
| EBITDA | 171.79M |
| Net Income | 24.85M |
| Diluted EPS | 0.1 |
Balance Sheet
| Total Cash | 134.03M |
| Total Cash/Share | 0.55 |
| Total Debt | 406.65M |
| Total Debt/Equity | 0.81 |
| Current Ratio | 1.03 |
| Book Value Per Share | 2.29 |
Price History
| 52-Week Change | -29.45 |
| 52-Week High | 15.2 |
| 52-Week Low | 6.93 |
| Moving Average 50 Days | 8.52 |
| Moving Average 200 Days | 10.12 |
Statistics
| Average Volume | 10.67M |
| Shares Outstanding | 258.4M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.77 |
| Last Split Factor | 6:5 |
| Last Split Date | July 08, 2016 |
AD
